A glimpse into the future of the percutaneous treatment of coronary chronic total occlusions

Gianluca Castaldi1, Alice Benedetti1, Carlo Zivelonghi1

  • 1Hartcentrum Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp, Belgium.

Insights

Coronary chronic total occlusion (CTO) percutaneous coronary intervention (PCI) faces challenges, especially post-coronary artery bypass graft (CABG). This review explores strategies, physiology

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Imaging
  • Vascular Biology

Background:

  • Coronary chronic total occlusion percutaneous coronary intervention (CTO PCI) is complex, particularly in patients with prior coronary artery bypass graft (CABG).
  • Optimal strategies for post-CABG CTOs and the role of physiological assessment remain areas of active investigation.
  • Current clinical practice and training for CTO PCI often overlook the potential of coronary computed tomography angiography (CCTA) for procedural planning.

Purpose of the Study:

  • To address key challenges and unanswered questions in CTO PCI.
  • To explore the utility of coronary computed tomography angiography (CCTA) for enhancing periprocedural planning in CTO PCI.
  • To evaluate the potential of minimizing stent implantation in CTO PCI to reduce late adverse events.

Main Methods:

  • Review of current literature and clinical practice regarding CTO PCI strategies.
  • Analysis of the role of physiological assessment in CTO PCI.
  • Exploration of advanced imaging techniques, including CCTA, for procedural planning.
  • Discussion of novel approaches, such as metal-free strategies, in CTO PCI.

Main Results:

  • Post-CABG CTOs present unique challenges requiring tailored strategies.
  • Physiological assessment may offer valuable insights but is limited by procedural complexity.
  • Coronary computed tomography angiography (CCTA), with appropriate expertise, can significantly improve procedural planning for CTO PCI.
  • Minimizing stent implantation in CTO PCI is a potential strategy to reduce late adverse events but poses technical challenges.

Conclusions:

  • Further research is needed to optimize CTO PCI, especially in post-CABG patients.
  • Integrating advanced imaging like CCTA into routine practice can enhance CTO PCI planning and outcomes.
  • Future directions in CTO PCI may involve innovative techniques and technologies to improve efficacy and safety.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
15
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
19
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
236